ANO31905

Anova Innovation Limited · Phase 1 active Biologic

At a glance

Generic name	ANO31905
Sponsor	Anova Innovation Limited
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ANO31905 CI brief — competitive landscape report
ANO31905 updates RSS · CI watch RSS
Anova Innovation Limited portfolio CI